Top

Published in:

11-08-2023 | Mood Disorders | Original Paper

Depression and Anxiety Symptoms and Treatment Utilization, and Associated HIV Outcomes among Adults with HIV in Rural Florida

Authors: Preeti Manavalan, Yancheng Li, Jon C. Mills, Awewura Kwara, Zhi Zhou, Alaina S. Ritter, Emma Spencer, Brian W. Pence, Robert L. Cook

Published in: AIDS and Behavior | Issue 1/2024

Abstract

Persons living with HIV (PLWH) and depression or anxiety in the rural South may have suboptimal HIV outcomes. We sought to examine the proportion of PLWH from rural Florida with symptoms of depression or anxiety, the proportion who received depression or anxiety treatment, and the relationship between untreated and treated symptoms of depression or anxiety and HIV outcomes. Cross-sectional survey data collected between 2014 and 2018 were analyzed. Among 187 PLWH residing in rural Florida (median age 49 years, 61.5%, male 45.5% Black), 127 (67.9%) met criteria for symptoms of depression and/or anxiety. Among these 127 participants, 60 (47.2%) were not on depression or anxiety treatment. Participants with untreated symptoms of depression and anxiety (OR 3.2, 95% CI 1.2–9.2, p = 0.03) and treated depression and anxiety with uncontrolled symptoms (OR 1.4, 95% CI 0.5–4.0, p = 0.52) were more likely to have viral non-suppression compared to those without depression or anxiety in an unadjusted bivariate analysis. Only the association between untreated symptoms of depression and anxiety and viral non-suppression was statistically significant, and when adjusting for social and structural confounders the association was attenuated and was no longer statistically significant. This suggests that social and structural barriers impact both mental health and HIV outcomes. Our findings support the need for increased mental health services and resources that address the social and structural barriers to care for PLWH in the rural South.

Gooden TE, Gardner M, Wang J, et al. The risk of mental illness in people living with HIV in the UK: a propensity score-matched cohort study. Lancet HIV. 2022;9(3):e172–81. https://doi.org/10.1016/S2352-3018(21)00319-2.CrossRefPubMed

DiPrete BL, Pence BW, Bengtson AM, et al. The Depression Treatment Cascade: disparities by Alcohol Use, Drug Use, and panic symptoms among patients in routine HIV Care in the United States. AIDS Behav. 2019;23(3):592–601. https://doi.org/10.1007/s10461-018-2282-3.CrossRefPubMedPubMedCentral

Schumacher JE, McCullumsmith C, Mugavero MJ, et al. Routine Depression Screening in an HIV Clinic Cohort identifies patients with Complex Psychiatric co-morbidities who show significant response to treatment. AIDS Behav. 2013;17(8):2781–91. https://doi.org/10.1007/s10461-012-0342-7.CrossRefPubMedPubMedCentral

Byrd KK, Hou JG, Hazen R, et al. Antiretroviral adherence level necessary for HIV viral suppression using Real-World Data. J Acquir Immune Defic Syndr. 2019;82(3):245–51. https://doi.org/10.1097/QAI.0000000000002142.CrossRefPubMedPubMedCentral

Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30. https://doi.org/10.7326/0003-4819-133-1-200007040-00004.CrossRefPubMed

Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17(5):377–81.CrossRefPubMedPubMedCentral

Evidence of HIV Treatment and Viral Suppression in Preventing the Sexual Transmission of HIV Transmission | HIV Risk and Prevention | HIV/AIDS | CDC. Published August 6, 2021. Accessed March 14., 2023. https://www.cdc.gov/hiv/risk/art/evidence-of-hiv-treatment.html.

Probst JC, Laditka SB, Moore CG, Harun N, Powell MP, Baxley EG. Rural-urban differences in depression prevalence: implications for family medicine. Fam Med. 2006;38(9):653–60.PubMed

Morales DA, Barksdale CL, Beckel-Mitchener AC. A call to action to address rural mental health disparities. J Clin Transl Sci. 2020;4(5):463–7. https://doi.org/10.1017/cts.2020.42.CrossRefPubMedPubMedCentral

10.

Whetten K, Reif SS, Napravnik S, et al. Substance abuse and symptoms of mental illness among HIV-positive persons in the Southeast. South Med J. 2005;98(1):9–14. https://doi.org/10.1097/01.SMJ.0000149371.37294.66.CrossRefPubMed

11.

Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr. 2006;42(3):298–306. https://doi.org/10.1097/01.qai.0000219773.82055.aa.CrossRefPubMed

12.

Remien RH, Stirratt MJ, Nguyen N, Robbins RN, Pala AN, Mellins CA. Mental health and HIV/AIDS: the need for an integrated response. AIDS. 2019;33(9):1411–20. https://doi.org/10.1097/QAD.0000000000002227.CrossRefPubMed

13.

Kempf MC, McLeod J, Boehme AK, et al. A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: implications for targeted interventions. AIDS Patient Care STDS. 2010;24(8):515–20. https://doi.org/10.1089/apc.2010.0065.CrossRefPubMed

14.

Moneyham L, McLeod J, Boehme A, et al. Perceived barriers to HIV care among HIV-infected women in the Deep South. J Assoc Nurses AIDS Care. 2010;21(6):467–77. https://doi.org/10.1016/j.jana.2010.03.003.CrossRefPubMed

15.

Reif S, Whetten K, Ostermann J, Raper JL. Characteristics of HIV-infected adults in the Deep South and their utilization of mental health services: a rural vs. urban comparison. AIDS Care. 2006;18(Suppl 1):10–7. https://doi.org/10.1080/09540120600838738.CrossRef

16.

Reif S, Whetten K, Lowe K, Ostermann J. Association of unmet needs for support services with medication use and adherence among HIV-infected individuals in the southeastern United States. AIDS Care. 2006;18(4):277–83. https://doi.org/10.1080/09540120500161868.CrossRefPubMed

17.

Pellowski JA. Barriers to care for rural people living with HIV: a review of domestic research and health care models. J Assoc Nurses AIDS Care. 2013;24(5):422–37. https://doi.org/10.1016/j.jana.2012.08.007.CrossRefPubMedPubMedCentral

18.

Heckman TG, Somlai AM, Peters J, et al. Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care. 1998;10(3):365–75. https://doi.org/10.1080/713612410.CrossRefPubMed

19.

Reif S, Safley D, McAllaster C, Wilson E, Whetten K. State of HIV in the US Deep South. J Community Health. 2017;42(5):844–53. https://doi.org/10.1007/s10900-017-0325-8.CrossRefPubMed

20.

Reif S, Pence BW, Hall I, Hu X, Whetten K, Wilson E. HIV Diagnoses, Prevalence and Outcomes in Nine Southern States. J Community Health. 2015;40(4):642–51. https://doi.org/10.1007/s10900-014-9979-7.CrossRefPubMed

21.

Uphold CR, Rane D, Reid K, Tomar SL. Mental Health differences between Rural and Urban Men living with HIV infection in various age groups. J Community Health. 2005;30(5):355–75. https://doi.org/10.1007/s10900-005-5517-y.CrossRefPubMed

22.

Schalkoff CA, Lancaster KE, Gaynes BN, et al. The opioid and related drug epidemics in rural Appalachia: a systematic review of populations affected, risk factors, and infectious diseases. Subst Abus. 2020;41(1):35–69. https://doi.org/10.1080/08897077.2019.1635555.CrossRefPubMed

23.

Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV Epidemic: a plan for the United States. JAMA. 2019;321(9):844–5. https://doi.org/10.1001/jama.2019.1343.CrossRefPubMed

24.

Pence BW, Miller WC, Gaynes BN, Eron JJ. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;44(2):159–66. https://doi.org/10.1097/QAI.0b013e31802c2f51.CrossRefPubMed

25.

Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7. https://doi.org/10.1097/QAI.0b013e31822d490a.CrossRefPubMed

26.

Ibañez GE, Zhou Z, Cook CL, et al. The Florida Cohort study: methodology, initial findings and lessons learned from a multisite cohort of people living with HIV in Florida. AIDS Care. 2021;33(4):516–24. https://doi.org/10.1080/09540121.2020.1748867.CrossRefPubMed

27.

Florida Department of Health (FDOH). (2018). Epidemiological Profile, Florida: Continuum of HIV Care by County, 2017. Florida Department of Health (FDOH). (2018). Epidemiological Profile, Florida: Continuum of HIV Care by County, 2017. Available at: http://www.floridahealth.gov/diseases-and-conditions/aids/surveillance/epi-profiles/Epi_Profile_Tables_Florida_2018_Locked.xlsx.

28.

Bureau UC. ZIP Code Tabulation Areas (ZCTAs). Census.gov. Accessed March 13, 2023. https://www.census.gov/programs-surveys/geography/guidance/geo-areas/zctas.html.

29.

Bureau UC. 2010 Census Urban and Rural Classification and Urban Area Criteria. Census.gov. Accessed March 13, 2023. https://www.census.gov/programs-surveys/geography/guidance/geo-areas/urban-rural/2010-urban-rural.html.

30.

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13. https://doi.org/10.1046/j.1525-1497.2001.016009606.x.CrossRefPubMedPubMedCentral

31.

Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7. https://doi.org/10.1001/archinte.166.10.1092.CrossRefPubMed

32.

Wu Y, Levis B, Riehm KE, et al. Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis. Psychol Med. 2020;50(8):1368–80. https://doi.org/10.1017/S0033291719001314.CrossRefPubMed

33.

Algarin AB, Sheehan DM, Varas-Diaz N, et al. Enacted HIV-Related Stigma’s association with anxiety & Depression among People living with HIV (PLWH) in Florida. AIDS Behav. 2021;25(1):93–103. https://doi.org/10.1007/s10461-020-02948-5.CrossRefPubMedPubMedCentral

34.

Parisi CE, Varma DS, Wang Y, et al. Changes in Mental Health among People with HIV during the COVID-19 pandemic: qualitative and quantitative perspectives. AIDS Behav. 2022;26(6):1980–91. https://doi.org/10.1007/s10461-021-03547-8.CrossRefPubMedPubMedCentral

35.

Pence BW, Mills JC, Bengtson AM, et al. Association of increased chronicity of Depression with HIV Appointment Attendance, Treatment failure, and Mortality among HIV-Infected adults in the United States. JAMA Psychiatry. 2018;75(4):379–85. https://doi.org/10.1001/jamapsychiatry.2017.4726.CrossRefPubMedPubMedCentral

36.

Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8. https://doi.org/10.1001/archpsyc.58.8.721.CrossRefPubMed

37.

2016 National Survey on Drug Use and Health. Detailed tables. Center for behavioral Health Statistics and Quality. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2017.

38.

Bureau UC. New Census Data Show Differences Between Urban and Rural Populations. Census.gov. Accessed March 13, 2022. https://www.census.gov/newsroom/press-releases/2016/cb16-210.html.

39.

Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun. 2020;89:531–42. https://doi.org/10.1016/j.bbi.2020.05.048.CrossRefPubMedPubMedCentral

40.

Rajkumar RP. COVID-19 and mental health: a review of the existing literature. Asian J Psychiatr. 2020;52:102066. https://doi.org/10.1016/j.ajp.2020.102066.CrossRefPubMedPubMedCentral

41.

Pierce M, Hope H, Ford T, et al. Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population. The Lancet Psychiatry. 2020;7(10):883–92. https://doi.org/10.1016/S2215-0366(20)30308-4.CrossRefPubMedPubMedCentral

42.

Mental Health Care - Household Pulse Survey - COVID-19. Published April 20., 2022. Accessed May 13, 2023. https://www.cdc.gov/nchs/covid19/pulse/mental-health-care.htm.

43.

Winwood JJ, Fitzgerald L, Gardiner B, Hannan K, Howard C, Mutch A. Exploring the Social Impacts of the COVID-19 pandemic on people living with HIV (PLHIV): a scoping review. AIDS Behav. 2021;25(12):4125–40. https://doi.org/10.1007/s10461-021-03300-1.CrossRefPubMedPubMedCentral

44.

Douthit N, Kiv S, Dwolatzky T, Biswas S. Exposing some important barriers to health care access in the rural USA. Public Health. 2015;129(6):611–20. https://doi.org/10.1016/j.puhe.2015.04.001.CrossRefPubMed

45.

Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep. 2014;11(3):291–307. https://doi.org/10.1007/s11904-014-0220-1.CrossRefPubMedPubMedCentral

46.

Ironson G, O’Cleirigh C, Fletcher MA, et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med. 2005;67(6):1013–21. https://doi.org/10.1097/01.psy.0000188569.58998.c8.CrossRefPubMedPubMedCentral

47.

Leserman J, Petitto JM, Perkins DO, Folds JD, Golden RN, Evans DL. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. Arch Gen Psychiatry. 1997;54(3):279–85. https://doi.org/10.1001/archpsyc.1997.01830150105015.CrossRefPubMed

48.

Nurutdinova D, Chrusciel T, Zeringue A, et al. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans. AIDS. 2012;26(2):229–34. https://doi.org/10.1097/QAD.0b013e32834e1404.CrossRefPubMed

49.

Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med. 2014;47(3):259–69. https://doi.org/10.1007/s12160-013-9559-6.CrossRefPubMed

50.

Rooks-Peck CR, Adegbite AH, Wichser ME, et al. Mental health and retention in HIV care: a systematic review and meta-analysis. Health Psychol. 2018;37(6):574–85. https://doi.org/10.1037/hea0000606.CrossRefPubMedPubMedCentral

51.

Senn TE, Greenwood GL, Rao VR. Global mental health and HIV care: gaps and research priorities. J Int AIDS Soc. 2021;24(Suppl 2):e25714. https://doi.org/10.1002/jia2.25714.CrossRefPubMedPubMedCentral

52.

Sohn AH, Ross J, Wainberg ML. Barriers to mental healthcare and treatment for people living with HIV in the Asia-Pacific. J Int AIDS Soc. 2018;21(10):e25189. https://doi.org/10.1002/jia2.25189.CrossRefPubMedPubMedCentral

53.

Kepley HO, Streeter RA. Closing behavioral health workforce gaps: a HRSA Program Expanding Direct Mental Health Service Access in Underserved Areas. Am J Prev Med. 2018;54(6 Suppl 3):190–S191. https://doi.org/10.1016/j.amepre.2018.03.006.CrossRef

54.

Andrilla CHA, Patterson DG, Garberson LA, Coulthard C, Larson EH. Geographic Variation in the supply of selected behavioral Health Providers. Am J Prev Med. 2018;54(6 Suppl 3):199–S207. https://doi.org/10.1016/j.amepre.2018.01.004.CrossRef

55.

Klein PW, Geiger T, Chavis NS, et al. The Health Resources and Services Administration’s Ryan White HIV/AIDS Program in rural areas of the United States: Geographic distribution, provider characteristics, and clinical outcomes. PLoS ONE. 2020;15(3):e0230121. https://doi.org/10.1371/journal.pone.0230121.CrossRefPubMedPubMedCentral

56.

Wroe EB, Kalanga N, Dunbar EL, et al. Expanding access to non-communicable disease care in rural Malawi: outcomes from a retrospective cohort in an integrated NCD-HIV model. BMJ Open. 2020;10(10):e036836. https://doi.org/10.1136/bmjopen-2020-036836.CrossRefPubMedPubMedCentral

57.

Sikkema KJ, Dennis AC, Watt MH, Choi KW, Yemeke TT, Joska JA. Improving mental health among people living with HIV: a review of intervention trials in low- and middle-income countries. Glob Ment Health (Camb). 2015;2:e19. https://doi.org/10.1017/gmh.2015.17.CrossRefPubMed

58.

Udedi M, Stockton MA, Kulisewa K, et al. Integrating depression management into HIV primary care in central Malawi: the implementation of a pilot capacity building program. BMC Health Serv Res. 2018;18(1):593. https://doi.org/10.1186/s12913-018-3388-z.CrossRefPubMedPubMedCentral

59.

Mental health action plan 2013–2020. Accessed March 13., 2023. https://www.who.int/publications-detail-redirect/9789241506021.

60.

Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. (2016). Accessed March 13, 2023. https://www.who.int/publications-detail-redirect/9789241549684.

61.

O’Halloran Leach E, Lu H, Caballero J, Thomas JE, Spencer EC, Cook RL. Defining the optimal cut-point of self-reported ART adherence to achieve viral suppression in the era of contemporary HIV therapy: a cross-sectional study. AIDS Res Ther. 2021;18(1):36. https://doi.org/10.1186/s12981-021-00358-8.CrossRefPubMedPubMedCentral

Title: Depression and Anxiety Symptoms and Treatment Utilization, and Associated HIV Outcomes among Adults with HIV in Rural Florida
Authors: Preeti Manavalan
Yancheng Li
Jon C. Mills
Awewura Kwara
Zhi Zhou
Alaina S. Ritter
Emma Spencer
Brian W. Pence
Robert L. Cook
Publication date: 11-08-2023
Publisher: Springer US
Keywords: Mood Disorders
Affective Disorder
Anxiety
Human Immunodeficiency Virus
Published in: AIDS and Behavior / Issue 1/2024
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-023-04147-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2024

The Intersection of Age and HIV Status for Black Sexual Minority Men (BSMM): A Social Network Analysis

Overall, Direct, Spillover, and Composite Effects of Components of a Peer-Driven Intervention Package on Injection Risk Behavior Among People Who Inject Drugs in the HPTN 037 Study

Social/Sexual Networks of People Newly Diagnosed with HIV in Ibadan, Nigeria

HIV Testing Disruptions and Service Adaptations During the COVID-19 Pandemic: A Systematic Literature Review

Piloting Safety and Stabilization: A Multi-component Trauma Intervention to Improve HIV Viral Suppression, Retention in Care, and Post-traumatic Stress Disorder in a Southern United States HIV Service Organization

Depressive Symptoms, the Impact on ART Continuation, and Factors Associated with Symptom Improvement Among a Cohort of People Living with HIV in British Columbia, Canada

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage